期刊文献+

艾司西酞普兰与帕罗西汀治疗老年性抑郁症对比分析

Comparative Analysis of Escitalopram and Paroxetine in Treatment of Senile Depression
下载PDF
导出
摘要 目的研究艾司西酞普兰、帕罗西汀治疗老年性抑郁症的效果。方法在该院2015年2月—2017年1月收治的老年抑郁症患者中选出60例随机分组,A组患者给予艾司西酞普兰治疗,B组患者给予帕罗西汀治疗,对比两组患者的治疗效果。结果 (1)A组在治疗2、4、8周后,其HADM评分分别变为(15.10±0.65)分、(12.28±0.54)分、(7.46±0.32)分,B组为(18.46±1.05)分,(15.47±0.75)分,(10.27±0.57)分,经数据分析,差异有统计学意义(P<0.05);(2)A组发生不良反应发生率是13.33%,较B组的不良反应发生率低出约27.00%,经数据分析,差异有统计学意义(P<0.05);(3)A组在治疗2、4、8周后,以第8周为例,其工作/学习、社交生活、家庭生活/家庭责任的评分分别是(2.11±0.15)分、(2.03±0.21)分、(1.67±0.20)分,B组为(2.89±0.18)分,(2.56±0.23)分,(2.38±0.28)分,经数据分析,差异有统计学意义(P<0.05)。结论在老年性抑郁症的治疗中应用艾司西酞普兰治疗效果确切,有助于促进患者社会功能的恢复,且安全性高,值得推广。 Objective To research the effect of escitalopram and paroxetine in treatment of senile depression.Methods 60 cases of senile depression patients admitted and treated in our hospital from February 2015 to January 2017 were randomly divided into two groups,the group A were treated with escitalopram,while the group B were treated with paroxetine,and the treatment effect was compared between the two groups.Results After the two-week,four-week and 8-week treatment,the HADM scores were respectively(15.10±0.65)points,(12.28±0.54)points,(7.46±0.32)points in the group A,which were about(18.46±1.05)points,(15.47±0.75)points,(10.27±0.57)points in the group B,and the differences were statistically significant(P<0.05);the incidence rate of adverse reactions in the group A was 13.33%,which was about 27.00%lower than that in the group B,and the difference was statistically significant(P<0.05);the work/study,social life,family life/family responsibility in the two-week,four-week and 8-week treatment in the group A were respectively(2.11±0.15)points,(2.03±0.21)points,(1.67±0.20)points,which were about(2.89±0.18)points,(2.56±0.23)points,(2.38±0.28)points in the group B,and the differences were statistically significant,(P<0.05).Conclusion The application effect of escitalopram in treatment of senile depression is definite,which contributes to promoting the recovery of social function with high safety,and it is worth promotion.
作者 刘丽 LIU Li(Department of Psychiatry,PLA 102 Hospital,Changzhou,Jiangsu Province,213003 China)
出处 《系统医学》 2017年第15期1-3,共3页 Systems Medicine
关键词 艾司西酞普兰 帕罗西汀 老年性抑郁症 社会功能 Escitalopram Paroxetine Senile depression Social function
  • 相关文献

参考文献12

二级参考文献64

  • 1吴盛各,徐健,郭华贵.艾司西酞普兰与帕罗西汀治疗老年脑卒中后抑郁的对照研究[J].黑龙江医学,2013,37(1):8-10. 被引量:13
  • 2刘文,李焕德.新型抗抑郁药物的临床应用及其作用机制研究进展[J].中国药房,2007,18(1):66-68. 被引量:30
  • 3汪向东 龚耀先 姚树桥等.老年抑郁量表.中国心理卫生杂志,1999,:195-197.
  • 4汪向东,王希林,马弘.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,2001:161-167.
  • 5陈桂根.艾司西酞普兰与帕罗西汀治疗首发老年抑郁症疗效及安全性评价[J].中国中医药科技,2014,14(z2):207-208.
  • 6中华医学会精神科学会.中国精神障碍分类与诊断标准(CCMD.3)[M].济南:山东科学技术出版社,2001,8647.
  • 7沈渔?.精神病学[M].5版.北京:人民卫生出版社,2010:586-589.
  • 8Alexopoulos GS,Borson S,Cuthbert BN et al.Aesessment of late life depression[J].Biol Psychiatry,2002,52(3):164-174.
  • 9范肖冬,汪向东,于欣,等译.国际疾病分类第10版精神和行为障碍分类标准[M].北京:人民卫生出版社,1993:97-104.
  • 10Mork A,Kreilgaard D,Sanchex C.The R-enantiomer of citalopram counteracls escitalopram-in duced increase in extraceliular 5-HT in the frontal cortex of freely moring rats[J].Nevropharmacology,2003,45(2):167-173.

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部